Mao,
Liu,
Wen,
Tan,
Fu,
Young,
Ronan,
Alvear,
Wildenberg,
Oetting,
Atwood,
Wilkin,
King,
Kaiser,
Uebelacker,
Abel,
Birkmann,
Trümper,
Schmalenberg,
Karakas,
Metzner,
Hossfeld,
Bischoff,
Franke,
Reiser,
Müller,
Mantovani,
Grundeis,
Rothmann,
von Seydewitz,
Mesters,
Steinhauer,
Krahl,
Schumacher,
Kneba,
Baudis,
Schmitz,
Pfab,
Köppler,
Parwaresch,
Pfreundschuh,
Havemann,
Mlekusch,
Mlekusch,
Minar,
Haumer,
Kopp,
Ahmadi,
Lehrner,
Schillinger,
Bech-Hansen,
Naylor,
Maybaum,
Pearce,
Koop,
Fishman,
Mets,
Musarella,
Boycott,
Halfter,
Winzen,
Bishop,
Eller,
Cohen,
Arnold,
Uzvolgyi,
Cano,
St John,
Yamamoto,
Lu,
Le,
Bechara,
Dolan,
Hindes,
Doherty,
Boucher,
Sorenson,
Lowney,
Virgili,
Menchini,
Challa,
Hauser,
Luna,
Freedman,
Pericak-Vance,
Yang,
McDonald,
Allingham,
- A second locus for familial high myopia maps to chromosome 12q. Young, T.L., Ronan, S.M., Alvear, A.B., Wildenberg, S.C., Oetting, W.S., Atwood, L.D., Wilkin, D.J., King, R.A. Am. J. Hum. Genet. (1998)
- Cysteine substitutions in epidermal growth factor-like domains of fibrillin-1: distinct effects on biochemical and clinical phenotypes. Schrijver, I., Liu, W., Brenn, T., Furthmayr, H., Francke, U. Am. J. Hum. Genet. (1999)
- Variation in the vitreous phenotype of Stickler syndrome can be caused by different amino acid substitutions in the X position of the type II collagen Gly-X-Y triple helix. Richards, A.J., Baguley, D.M., Yates, J.R., Lane, C., Nicol, M., Harper, P.S., Scott, J.D., Snead, M.P. Am. J. Hum. Genet. (2000)
- A single amino acid substitution (G103D) in the type II collagen triple helix produces Kniest dysplasia. Wilkin, D.J., Bogaert, R., Lachman, R.S., Rimoin, D.L., Eyre, D.R., Cohn, D.H. Hum. Mol. Genet. (1994)
- Clinical homogeneity and genetic heterogeneity in Weill-Marchesani syndrome. Faivre, L., Dollfus, H., Lyonnet, S., Alembik, Y., Mégarbané, A., Samples, J., Gorlin, R.J., Alswaid, A., Feingold, J., Le Merrer, M., Munnich, A., Cormier-Daire, V. Am. J. Med. Genet. A (2003)
- Genes for super-intelligence? Sofaer, J.A., Emery, A.E. J. Med. Genet. (1981)
- Optical compensation for night myopia based on dark focus and CA/C ratio. Kotulak, J.C., Morse, S.E., Rabin, J.C. Invest. Ophthalmol. Vis. Sci. (1995)
- Is there improvement of "vascular depression" after carotid artery stent placement? Mlekusch, W., Mlekusch, I., Minar, E., Haumer, M., Kopp, C.W., Ahmadi, R., Lehrner, J., Schillinger, M. Radiology. (2006)
- Decision-making and addiction (part II): myopia for the future or hypersensitivity to reward? Bechara, A., Dolan, S., Hindes, A. Neuropsychologia. (2002)
- The complete form of X-linked congenital stationary night blindness is caused by mutations in a gene encoding a leucine-rich repeat protein. Pusch, C.M., Zeitz, C., Brandau, O., Pesch, K., Achatz, H., Feil, S., Scharfe, C., Maurer, J., Jacobi, F.K., Pinckers, A., Andreasson, S., Hardcastle, A., Wissinger, B., Berger, W., Meindl, A. Nat. Genet. (2000)
- Loss-of-function mutations in a calcium-channel alpha1-subunit gene in Xp11.23 cause incomplete X-linked congenital stationary night blindness. Bech-Hansen, N.T., Naylor, M.J., Maybaum, T.A., Pearce, W.G., Koop, B., Fishman, G.A., Mets, M., Musarella, M.A., Boycott, K.M. Nat. Genet. (1998)
- An animal model of myopia. Raviola, E., Wiesel, T.N. N. Engl. J. Med. (1985)
- Verteporfin therapy of subfoveal choroidal neovascularization in pathologic myopia: 2-year results of a randomized clinical trial--VIP report no. 3. Blinder, K.J., Blumenkranz, M.S., Bressler, N.M., Bressler, S.B., Donato, G., Lewis, H., Lim, J.I., Menchini, U., Miller, J.W., Mones, J.M., Potter, M.J., Pournaras, C., Reaves, A., Rosenfeld, P., Schachat, A.P., Schmidt-Erfurth, U., Sickenberg, M., Singerman, L.J., Slakter, J.S., Strong, H.A., Virgili, G., Williams, G.A. Ophthalmology (2003)
- Do aspirin-like analgesics protect against cataract? A case-control study. van Heyningen, R., Harding, J.J. Lancet (1986)
- The neurotoxicity of antibacterial agents. Snavely, S.R., Hodges, G.R. Ann. Intern. Med. (1984)
- Randomized study to evaluate the use of high-dose therapy as part of primary treatment for "aggressive" lymphoma. Kaiser, U., Uebelacker, I., Abel, U., Birkmann, J., Trümper, L., Schmalenberg, H., Karakas, T., Metzner, B., Hossfeld, D.K., Bischoff, H.G., Franke, A., Reiser, M., Müller, P., Mantovani, L., Grundeis, M., Rothmann, F., von Seydewitz, C.U., Mesters, R.M., Steinhauer, E.U., Krahl, D., Schumacher, K., Kneba, M., Baudis, M., Schmitz, N., Pfab, R., Köppler, H., Parwaresch, R., Pfreundschuh, M., Havemann, K. J. Clin. Oncol. (2002)
- High-grade endometrial carcinoma in tamoxifen-treated breast cancer patients. Magriples, U., Naftolin, F., Schwartz, P.E., Carcangiu, M.L. J. Clin. Oncol. (1993)
- Effect of transfected interleukin-6 in non-tumorigenic and tumorigenic rat urothelial cell lines. Okamoto, M., Oyasu, R. Int. J. Cancer (1996)
- Antisense RNA-mediated reduction of p53 induces malignant phenotype in nontumorigenic rat urothelial cells. Okamoto, M., Hattori, K., Fujimoto, K., Tanaka, Y., Gloosby, C.L., Oyasu, R. Carcinogenesis (1998)
- Sequence variants in the transforming growth beta-induced factor (TGIF) gene are not associated with high myopia. Scavello, G.S., Paluru, P.C., Ganter, W.R., Young, T.L. Invest. Ophthalmol. Vis. Sci. (2004)
- A comparative histologic study of the fibrillin microfibrillar system in the lens capsule of normal subjects and subjects with Marfan syndrome. Mir, S., Wheatley, H.M., Hussels, I.E., Whittum-Hudson, J.A., Traboulsi, E.I. Invest. Ophthalmol. Vis. Sci. (1998)
- Clinical description and exclusion of candidate genes in a novel autosomal recessively inherited vitreoretinal dystrophy. Sarra, G.M., Weigell-Weber, M., Kotzot, D., Niemeyer, G., Messmer, E., Hergersberg, M. Arch. Ophthalmol. (2003)
- Pathologic myopia and choroidal neovascularization. Hotchkiss, M.L., Fine, S.L. Am. J. Ophthalmol. (1981)
- COL2A1 exon 2 mutations: relevance to the Stickler and Wagner syndromes. Richards, A.J., Martin, S., Yates, J.R., Scott, J.D., Baguley, D.M., Pope, F.M., Snead, M.P. The British journal of ophthalmology. (2000)
- Diastolic subclinical primary alterations in Marfan syndrome and Marfan-related disorders. Porciani, M.C., Giurlani, L., Chelucci, A., Pepe, G., Giusti, B.H., Brunelli, T., Attanasio, M., Martinucci, P., Fattrori, R., Abbatea, R., Gensini, G.F. Clinical cardiology. (2002)
- Possible role of dimethylarsinous acid in dimethylarsinic acid-induced urothelial toxicity and regeneration in the rat. Cohen, S.M., Arnold, L.L., Uzvolgyi, E., Cano, M., St John, M., Yamamoto, S., Lu, X., Le, X.C. Chem. Res. Toxicol. (2002)
- Splicing mutations of 54-bp exons in the COL11A1 gene cause Marshall syndrome, but other mutations cause overlapping Marshall/Stickler phenotypes. Annunen, S., Körkkö, J., Czarny, M., Warman, M.L., Brunner, H.G., Kääriäinen, H., Mulliken, J.B., Tranebjaerg, L., Brooks, D.G., Cox, G.F., Cruysberg, J.R., Curtis, M.A., Davenport, S.L., Friedrich, C.A., Kaitila, I., Krawczynski, M.R., Latos-Bielenska, A., Mukai, S., Olsen, B.R., Shinno, N., Somer, M., Vikkula, M., Zlotogora, J., Prockop, D.J., Ala-Kokko, L. Am. J. Hum. Genet. (1999)
- Photodynamic therapy with verteporfin for subfoveal choroidal neovascularisation of pathologic myopia in Chinese eyes: a prospective series of 1 and 2 year follow up. Lam, D.S., Chan, W.M., Liu, D.T., Fan, D.S., Lai, W.W., Chong, K.K. The British journal of ophthalmology. (2004)
- Transient myopia following metronidazole treatment for Trichomonas vaginalis. Grinbaum, A., Ashkenazi, I., Avni, I., Blumenthal, M. JAMA (1992)
- Exposure to dioxins as a risk factor for soft tissue sarcoma: a population-based case-control study. Eriksson, M., Hardell, L., Adami, H.O. J. Natl. Cancer Inst. (1990)
- Regulation of eye size by the retinal basement membrane and vitreous body. Halfter, W., Winzen, U., Bishop, P.N., Eller, A. Invest. Ophthalmol. Vis. Sci. (2006)
- Isoform-specific changes in scleral transforming growth factor-beta expression and the regulation of collagen synthesis during myopia progression. Jobling, A.I., Nguyen, M., Gentle, A., McBrien, N.A. J. Biol. Chem. (2004)
- Interferon regulatory factor expression in human breast cancer. Doherty, G.M., Boucher, L., Sorenson, K., Lowney, J. Ann. Surg. (2001)
- High-grade and hormone-treated prostate cancer express high levels of thymidylate synthase. Inoue, T., Segawa, T., Shiraishi, T., Yamada, T., Kinukawa, N., Yoshida, T., Toda, Y., Shimizu, Y., Nakamura, E., Kinoshita, H., Kamoto, T., Ogawa, O. BJU Int. (2006)
- Form-deprivation myopia induces activation of scleral matrix metalloproteinase-2 in tree shrew. Guggenheim, J.A., McBrien, N.A. Invest. Ophthalmol. Vis. Sci. (1996)
- Basic fibroblast growth factor suppresses retinal neuronal apoptosis in form-deprivation myopia in chicks. Mao, J., Liu, S., Wen, D., Tan, X., Fu, C. Curr. Eye Res. (2006)
- Autosomal dominant rhegmatogenous retinal detachment associated with an Arg453Ter mutation in the COL2A1 gene. Go, S.L., Maugeri, A., Mulder, J.J., van Driel, M.A., Cremers, F.P., Hoyng, C.B. Invest. Ophthalmol. Vis. Sci. (2003)
- Evaluation of Lipin 2 as a candidate gene for autosomal dominant 1 high-grade myopia. Zhou, J., Young, T.L. Gene (2005)
- Posterior chorioretinal atrophy and vitreous phenotype in a family with Stickler syndrome from a mutation in the COL2A1 gene. Vu, C.D., Brown, J., Körkkö, J., Ritter, R., Edwards, A.O. Ophthalmology (2003)
- Juvenile bilateral lens dislocation and glaucoma associated with a novel mutation in the fibrillin 1 gene. Challa, P., Hauser, M.A., Luna, C.C., Freedman, S.F., Pericak-Vance, M., Yang, J., McDonald, M.T., Allingham, R.R. Mol. Vis. (2006)
- Selective occlusion of subfoveal choroidal neovascularization in pathologic myopia using a new technique of ingrowth site treatment. Costa, R.A., Calucci, D., Teixeira, L.F., Cardillo, J.A., Bonomo, P.P. Am. J. Ophthalmol. (2003)
- Laser photocoagulation for choroidal neovascularisation in pathologic myopia. Virgili, G., Menchini, F. Cochrane database of systematic reviews (Online) (2005)